BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,979,138 | +1144.9% | 376,100 | +1096.6% | 0.03% | +1033.3% |
Q1 2021 | $319,643 | +741.2% | 31,430 | +66.9% | 0.00% | – |
Q1 2020 | $38,000 | -96.5% | 18,829 | -94.0% | 0.00% | -100.0% |
Q4 2019 | $1,087,000 | +274.8% | 315,000 | +587.8% | 0.01% | +300.0% |
Q4 2016 | $290,000 | +62.9% | 45,800 | +13.1% | 0.00% | +100.0% |
Q3 2016 | $178,000 | – | 40,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |